Article Text

Download PDFPDF
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards
  1. Abi Jenkins1,2,
  2. Steven Shanu3,
  3. Conor Jamieson3,
  4. Mark Santillo4
  1. 1Pharmacy, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  2. 2Pharmacy, University of Birmingham, Birmingham, UK
  3. 3Pharmacy Department, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
  4. 4Quality Assurance, Torbay and South Devon NHS Foundation Trust, Torquay, Torbay, UK
  1. Correspondence to Dr Abi Jenkins, Pharmacy, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK; abi.jenkins2{at}nhs.net

Abstract

Background In order to use aseptically prepared elastomeric infusers, outpatient parenteral antimicrobial therapy (OPAT) services require extended stability data for antimicrobial agents to assign a product shelf-life. In the UK, the relevant standards for stability testing and shelf-life assignment are published in ‘A Standard Protocol for Deriving and Assessment of Stability—Part 1 (Aseptic Preparations—Small Molecules), commonly called the Yellow Covered Document (YCD). A previous systematic review published in 2017 failed to identify data on the stability of antimicrobials in elastomeric devices for OPAT services that met YCD requirements in force at the time. The aim of this review was to update that search, following a subsequent change to YCD requirements in 2017 and 2019 and expand that dataset to identify progress made in providing assurance about the stability of antimicrobial agents for OPAT services.

Methods Searches were undertaken for papers relating to extended stability of antimicrobials. Citations were included when antimicrobial shelf-life was assessed using a stability-indicating method and considered a period of storage, either refrigerated or at room temperature, followed by in-use testing at a temperature at or above 32°C.

Results Of 267 initial citations, six met the inclusion criteria and underwent full text review for data extraction. Included antimicrobials were cefazolin, ceftazidime, piperacillin/tazobactam, flucloxacillin and ceftolozane/tazobactam. Of these, only flucloxacillin and piperacillin demonstrated YCD compliant stability over the 24-hour infusion period while cefazolin, ceftazidime and ceftolozane/tazobactam could be infused over 12-hour period.

Conclusions Contrary to the position found in 2017 review, high-quality data are now available to support the use of a number of antimicrobial agents in extended infusion in elastomeric devices for OPAT services. There is a need to expand the dataset, as well as developing international consensus on the ideal parameters for stability assessment of such infusions in elastomeric devices.

  • drug administration routes
  • microbiology
  • drug compounding
  • education
  • pharmacy
  • continuing
  • administration
  • intravenous

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

Statistics from Altmetric.com

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.